Focused ultrasound enhanced molecular imaging and gene therapy for multifusion reporter gene in glioma-bearing rat model

Feng Yi Yang, Wen Yuan Chang, Wei Ting Lin, Jeng Jong Hwang, Yi Chun Chien, Hsin Ell Wang, Min Lan Tsai

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The ability to monitor the responses of and inhibit the growth of brain tumors during gene therapy has been severely limited due to the blood-brain barrier (BBB). A previous study has demonstrated the feasibility of noninvasive in vivo imaging with 123I-2'-fluoro-2'-deoxy-5-iodo-1-β-D-arabinofuranosyluracil (123I-FIAU) for monitoring herpes simplex virus type 1 thymidine kinase (HSV1-tk) cancer gene expression in an experimental animal model. Here, we tested the enhancement of SPECT with 123I-FIAU and ganciclovir (GCV) treatment in brain tumors after BBB disruption induced by focused ultrasound (FUS) in the presence of microbubbles. We established an orthotopic F98 glioma-bearing rat model with trifusion reporter genes. The results of this study showed that the rat model of HSV1-tk-expressing glioma cells could be successfully detected by SPECT imaging after FUS-induced BBB disruption on day 10 after implantation. Compared to the control group, animals receiving the GCV with or without sonication exhibited a significant antitumor activity (P < 0.05) of glioma cells on day 16 after implantation. Moreover, combining sonication with GCV significantly inhibited tumor growth compared with GCV alone. This study demonstrated that FUS may be used to deliver a wide variety of theranostic agents to the brain for molecular imaging and gene therapy in brain diseases.

Original languageEnglish
Pages (from-to)36260-36268
Number of pages9
JournalOncotarget
Volume6
Issue number34
DOIs
Publication statusPublished - Jan 1 2015
Externally publishedYes

Fingerprint

Ganciclovir
Molecular Imaging
Reporter Genes
Glioma
Genetic Therapy
Arabinofuranosyluracil
Blood-Brain Barrier
Sonication
Thymidine Kinase
Human Herpesvirus 1
Single-Photon Emission-Computed Tomography
Brain Neoplasms
Microbubbles
Neoplasm Genes
Brain Diseases
Growth
Neuroimaging
Animal Models
Gene Expression
Control Groups

Keywords

  • Blood-brain barrier
  • Brain tumor
  • Focused ultrasound
  • Gene therapy
  • Molecular imaging

ASJC Scopus subject areas

  • Oncology

Cite this

Focused ultrasound enhanced molecular imaging and gene therapy for multifusion reporter gene in glioma-bearing rat model. / Yang, Feng Yi; Chang, Wen Yuan; Lin, Wei Ting; Hwang, Jeng Jong; Chien, Yi Chun; Wang, Hsin Ell; Tsai, Min Lan.

In: Oncotarget, Vol. 6, No. 34, 01.01.2015, p. 36260-36268.

Research output: Contribution to journalArticle

Yang, Feng Yi ; Chang, Wen Yuan ; Lin, Wei Ting ; Hwang, Jeng Jong ; Chien, Yi Chun ; Wang, Hsin Ell ; Tsai, Min Lan. / Focused ultrasound enhanced molecular imaging and gene therapy for multifusion reporter gene in glioma-bearing rat model. In: Oncotarget. 2015 ; Vol. 6, No. 34. pp. 36260-36268.
@article{87c0656c0ab54668ad969e28e03c90b8,
title = "Focused ultrasound enhanced molecular imaging and gene therapy for multifusion reporter gene in glioma-bearing rat model",
abstract = "The ability to monitor the responses of and inhibit the growth of brain tumors during gene therapy has been severely limited due to the blood-brain barrier (BBB). A previous study has demonstrated the feasibility of noninvasive in vivo imaging with 123I-2'-fluoro-2'-deoxy-5-iodo-1-β-D-arabinofuranosyluracil (123I-FIAU) for monitoring herpes simplex virus type 1 thymidine kinase (HSV1-tk) cancer gene expression in an experimental animal model. Here, we tested the enhancement of SPECT with 123I-FIAU and ganciclovir (GCV) treatment in brain tumors after BBB disruption induced by focused ultrasound (FUS) in the presence of microbubbles. We established an orthotopic F98 glioma-bearing rat model with trifusion reporter genes. The results of this study showed that the rat model of HSV1-tk-expressing glioma cells could be successfully detected by SPECT imaging after FUS-induced BBB disruption on day 10 after implantation. Compared to the control group, animals receiving the GCV with or without sonication exhibited a significant antitumor activity (P < 0.05) of glioma cells on day 16 after implantation. Moreover, combining sonication with GCV significantly inhibited tumor growth compared with GCV alone. This study demonstrated that FUS may be used to deliver a wide variety of theranostic agents to the brain for molecular imaging and gene therapy in brain diseases.",
keywords = "Blood-brain barrier, Brain tumor, Focused ultrasound, Gene therapy, Molecular imaging",
author = "Yang, {Feng Yi} and Chang, {Wen Yuan} and Lin, {Wei Ting} and Hwang, {Jeng Jong} and Chien, {Yi Chun} and Wang, {Hsin Ell} and Tsai, {Min Lan}",
year = "2015",
month = "1",
day = "1",
doi = "10.18632/oncotarget.5389",
language = "English",
volume = "6",
pages = "36260--36268",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "34",

}

TY - JOUR

T1 - Focused ultrasound enhanced molecular imaging and gene therapy for multifusion reporter gene in glioma-bearing rat model

AU - Yang, Feng Yi

AU - Chang, Wen Yuan

AU - Lin, Wei Ting

AU - Hwang, Jeng Jong

AU - Chien, Yi Chun

AU - Wang, Hsin Ell

AU - Tsai, Min Lan

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The ability to monitor the responses of and inhibit the growth of brain tumors during gene therapy has been severely limited due to the blood-brain barrier (BBB). A previous study has demonstrated the feasibility of noninvasive in vivo imaging with 123I-2'-fluoro-2'-deoxy-5-iodo-1-β-D-arabinofuranosyluracil (123I-FIAU) for monitoring herpes simplex virus type 1 thymidine kinase (HSV1-tk) cancer gene expression in an experimental animal model. Here, we tested the enhancement of SPECT with 123I-FIAU and ganciclovir (GCV) treatment in brain tumors after BBB disruption induced by focused ultrasound (FUS) in the presence of microbubbles. We established an orthotopic F98 glioma-bearing rat model with trifusion reporter genes. The results of this study showed that the rat model of HSV1-tk-expressing glioma cells could be successfully detected by SPECT imaging after FUS-induced BBB disruption on day 10 after implantation. Compared to the control group, animals receiving the GCV with or without sonication exhibited a significant antitumor activity (P < 0.05) of glioma cells on day 16 after implantation. Moreover, combining sonication with GCV significantly inhibited tumor growth compared with GCV alone. This study demonstrated that FUS may be used to deliver a wide variety of theranostic agents to the brain for molecular imaging and gene therapy in brain diseases.

AB - The ability to monitor the responses of and inhibit the growth of brain tumors during gene therapy has been severely limited due to the blood-brain barrier (BBB). A previous study has demonstrated the feasibility of noninvasive in vivo imaging with 123I-2'-fluoro-2'-deoxy-5-iodo-1-β-D-arabinofuranosyluracil (123I-FIAU) for monitoring herpes simplex virus type 1 thymidine kinase (HSV1-tk) cancer gene expression in an experimental animal model. Here, we tested the enhancement of SPECT with 123I-FIAU and ganciclovir (GCV) treatment in brain tumors after BBB disruption induced by focused ultrasound (FUS) in the presence of microbubbles. We established an orthotopic F98 glioma-bearing rat model with trifusion reporter genes. The results of this study showed that the rat model of HSV1-tk-expressing glioma cells could be successfully detected by SPECT imaging after FUS-induced BBB disruption on day 10 after implantation. Compared to the control group, animals receiving the GCV with or without sonication exhibited a significant antitumor activity (P < 0.05) of glioma cells on day 16 after implantation. Moreover, combining sonication with GCV significantly inhibited tumor growth compared with GCV alone. This study demonstrated that FUS may be used to deliver a wide variety of theranostic agents to the brain for molecular imaging and gene therapy in brain diseases.

KW - Blood-brain barrier

KW - Brain tumor

KW - Focused ultrasound

KW - Gene therapy

KW - Molecular imaging

UR - http://www.scopus.com/inward/record.url?scp=84946893370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946893370&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.5389

DO - 10.18632/oncotarget.5389

M3 - Article

VL - 6

SP - 36260

EP - 36268

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 34

ER -